Sales rise 23.56% to Rs 28.06 crore
Net Loss of Sun Pharma Advanced Research Company reported to Rs 56.72 crore in the quarter ended March 2021 as against net loss of Rs 99.54 crore during the previous quarter ended March 2020. Sales rose 23.56% to Rs 28.06 crore in the quarter ended March 2021 as against Rs 22.71 crore during the previous quarter ended March 2020.For the full year,net loss reported to Rs 151.14 crore in the year ended March 2021 as against net loss of Rs 312.40 crore during the previous year ended March 2020. Sales rose 229.29% to Rs 252.96 crore in the year ended March 2021 as against Rs 76.82 crore during the previous year ended March 2020.
ParticularsQuarter EndedYear EndedMar. 2021Mar. 2020% Var.Mar. 2021Mar. 2020% Var.Sales28.0622.71 24 252.9676.82 229 OPM %-179.72-433.11 --53.36-403.55 - PBDT-54.12-96.81 44 -140.22-302.92 54 PBT-56.72-99.54 43 -151.14-312.40 52 NP-56.72-99.54 43 -151.14-312.40 52
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
